← Leaderboards
Derek Russell
University Of Alabama At Birmingham
$823,500
Attributed
$823,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $164.9K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$823,500 · 1
By mechanism
K08$823,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Surya P. Bhatt$9,442,896
- David T Curiel$31,690,411
- Clinton J. Grubbs$3,836,849
- Richard Mark Allman$7,670,574
- Kristopher R. Genschmer$1,930,500
Others in their field
Other Emerging Leaders on “Disorder Risk”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy M Willson · University Of Cape Town$32,741,597
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
Disorder RiskAlveolarAlveolar DestructionDisease ProgressionAttenuatedAutomobile DrivingBindingBiologicalDisease PhenotypeBiomarker PerformanceBronchoalveolar Lavage FluidCareer DevelopmentCause Of DeathCellsCharacteristicsChargeChronic BronchitisChronic Inflammatory DiseaseBiological MarkersAnimal ModelCohortCollagen Type IDesignEnvironment
Grant awards (5)
Activated Neutrophilic Exosome as Biomarker and Therapeutic Target in COPD$164,376
K08 · FY2024 · HL · contact PI
Activated Neutrophilic Exosome as Biomarker and Therapeutic Target in COPD$164,376
K08 · FY2023 · HL · contact PI
Activated Neutrophilic Exosome as Biomarker and Therapeutic Target in COPD$164,916
K08 · FY2022 · HL · contact PI
Activated Neutrophilic Exosome as Biomarker and Therapeutic Target in COPD$164,916
K08 · FY2021 · HL · contact PI
Activated Neutrophilic Exosome as Biomarker and Therapeutic Target in COPD$164,916
K08 · FY2020 · HL · contact PI